These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38912931)

  • 21. Racial Disparities in Nephrology Consultation and Disease Progression among Veterans with CKD: An Observational Cohort Study.
    Suarez J; Cohen JB; Potluri V; Yang W; Kaplan DE; Serper M; Shah SP; Reese PP
    J Am Soc Nephrol; 2018 Oct; 29(10):2563-2573. PubMed ID: 30120108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between nephrologist care and progression of chronic kidney disease.
    Orlando LA; Owen WF; Matchar DB
    N C Med J; 2007; 68(1):9-16. PubMed ID: 17500426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy.
    Knight TG; Ryan K; Schaefer CP; D'Sylva L; Durden ED
    J Manag Care Pharm; 2010 Oct; 16(8):605-15. PubMed ID: 20866165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease referral practices among non-nephrology specialists: A single-centre experience.
    Buttigieg J; Mercieca L; Saliba A; Aquilina S; Farrugia E; Fava S
    Eur J Intern Med; 2016 Apr; 29():93-7. PubMed ID: 26809863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrology consultation and kidney failure in people with stage 4 chronic kidney disease: a population-based cohort study.
    Liu P; Quinn RR; Cortese G; Mahsin M; James MT; Ronksley PE; Quan H; Manns B; Hemmelgarn BR; Tonelli M; Ravani P
    J Nephrol; 2021 Aug; 34(4):1225-1234. PubMed ID: 33211302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
    Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
    JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projection of the health and economic impacts of Chronic kidney disease in the Chilean population.
    Walbaum M; Scholes S; Rojas R; Mindell JS; Pizzo E
    PLoS One; 2021; 16(9):e0256680. PubMed ID: 34495980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.
    Solid CA; Peter SA; Natwick T; Guo H; Collins AJ; Arduino JM
    Nephron; 2017; 136(2):54-61. PubMed ID: 28214902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with late presentation of patients with chronic kidney disease in nephrology consultation in Cameroon-a descriptive cross-sectional study.
    Marie Patrice H; Joiven N; Hermine F; Jean Yves B; Folefack François K; Enow Gloria A
    Ren Fail; 2019 Nov; 41(1):384-392. PubMed ID: 31106687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.
    Minutolo R; Lapi F; Chiodini P; Simonetti M; Bianchini E; Pecchioli S; Cricelli I; Cricelli C; Piccinocchi G; Conte G; De Nicola L
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1586-93. PubMed ID: 25074838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes in Patients With Chronic Kidney Disease and End-stage Renal Disease and Durable Left Ventricular Assist Device: Insights From the United States Renal Data System Database.
    Dalia T; Chan WC; Sauer AJ; Ranka S; Goyal A; Mastoris I; Pothuru S; Abicht T; Danter M; Vidic A; Gupta K; Tedford RJ; Cowger J; Fang JC; Shah Z
    J Card Fail; 2022 Nov; 28(11):1604-1614. PubMed ID: 35470059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.
    Curtis BM; Barrett BJ; Djurdjev O; Singer J; Levin A
    Am J Kidney Dis; 2007 Nov; 50(5):733-42. PubMed ID: 17954286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.
    Diamantidis CJ; Zepel L; Wang V; Smith VA; Hudson Scholle S; Tamayo L; Maciejewski ML
    Am J Nephrol; 2021; 52(12):949-957. PubMed ID: 34875668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.
    Gagnon-Sanschagrin P; Liang Y; Sanon M; Oberdhan D; Guérin A; Cloutier M
    J Med Econ; 2021; 24(1):193-201. PubMed ID: 33464936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.
    Lin E; Chertow GM; Yan B; Malcolm E; Goldhaber-Fiebert JD
    PLoS Med; 2018 Mar; 15(3):e1002532. PubMed ID: 29584720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.